SCHEMBL16049

SCHEMBL16049

CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@H]2Cc2ccc(F)cc2)cc1)C(F)(F)F

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 13/20 0.76
GCK P35557 7/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18209 1.00 GCKR (0.76) GCKRGCK
SCHEMBL16698 1.00 GCKR (0.76) GCKRGCK
SCHEMBL12077618 1.00 GCKR (0.76) GCKRGCK
SCHEMBL33241 1.00 GCKR (0.76) GCKRGCK
SCHEMBL12078767 1.00 GCKR (0.76) GCKRGCK
SCHEMBL16285 1.00 GCKR (0.76) GCKRGCK
SCHEMBL16293 0.93 GCKR (0.85) GCKRGCK
SCHEMBL16095 0.93 GCKR (0.85) GCKRGCK
SCHEMBL12089562 0.93 GCKR (0.73) GCKRGCK
SCHEMBL12089390 0.93 GCKR (0.73) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed